Canadian Biotech Company to Supply MDMA for Pending HMS Clinical Trial

Toronto-based MDMA manufacturer PharmAla Biotech signed a contract to supply Harvard Medical School researchers with the drug for a pending clinical trial, PharmAla announced in a Oct. 2 press release.